Dr. Cotton and Dr. Elmunzer

Division of Gastroenterology & Hepatology

The Division of Gastroenterology and Hepatology at the Medical University of South Carolina (MUSC) provides clinical, research, and educational services in all aspects of gastroenterology and hepatology medicine for patients located throughout South Carolina and the Southeastern United States. Our peers and our patients continue to rank the Department of Medicine programs among the best in the nation. In 2018, MUSC Health was once again recognized as high-performing in gastroenterology and GI surgery by U.S. News & World Report, meaning it ranks among the top 10 percent of hospitals in the nation for complex-care in that specialty.

Education

The MUSC Division of Gastroenterology and Hepatology Fellowship Program offers comprehensive training in digestive diseases, designed to produce competent, independent, board-certified subspecialists and clinical investigators after a three-year tenure. Upon completion of the training experiences, trainees will have the clinical, investigative and teaching skills necessary to take a leading role in academic and clinical gastroenterology.

Learn more about our Gastroenterology Fellowship Program

Research

In addition to being leaders in the clinic, Division faculty are also leaders in their respective areas of research which span such varied interests as biliopancreatic disease to esophageal reflux and inflammatory bowel disease, colon cancer and polyps, liver disease and liver failure, hepatopulmonary syndrome, nutrition and obesity, liver fibrosis, and liver transplantation.

Learn more about our Gastroenterology Research Program

Patient Care

The Division’s nationally recognized Digestive Disease Center brings together a multidisciplinary team of gastroenterologists, surgeons, hepatologists, and radiologists to provide the highest level of comprehensive care for patients with a wide variety of digestive diseases and disorders. Clinical services are coordinated within five sections:  liver disease, pancreatic and biliary disease, gastrointestinal cancer, functional and inflammatory bowel disease, and nutrition.

Learn more about our Patient Care services

 

Trimming the Fat

Liver

MUSC clinical trials hope to identify novel combinatorial therapies for NAFLD and NASH.